General
Updated Booster Guidance - 05/22/2022
The State of New Mexico should mandate insurance carriers within the state to cover
The State of New Mexico should mandate insurance carriers within the state to cover medications prescribed by physicians for stimulant use disorder that have shown to be effective, are still in trial, and have otherwise had an improved outcome in reducing the use of methamphetamines.
2022 Submitted Public Comment to the CDC Clinical Practice Guideline for Prescribing Opioids
Cannabis Quick Reference Guide (Spanish)
Cannabis Quick Reference Guide
SW Numbered Memo 2022-02 DDSD Supports Waiver Core Trainings Update
Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology - 04/21/2022
COVID-19 Vaccination Rule 3
Socialization and Sexuality Education (SSE) Adding Incentive Counties
Incentive County List Updated 4.1.2022
COVID-19 Vaccination and Treatment During Pregnancy
COVID-19 Vaccination and Treatment During Pregnancy - 04-07-2022
Joint Statement on COVID-19 Vaccination and Treatment During Pregnancy - 04-06-2022
COVID-19 Therapeutics Update - 04/05/2022
COVID-19 Therapeutics Update: Sotrovimab Pause & Updated NIH Treatment Guidelines - 04-05-2022
COVID Therapeutics - Quick Reference for Prescribers - 04-05-2022
HAN Alert Pediatric Ingestion of Cannabis Products
HAN Alert COVID-19 2nd Booster Dose Guidance
1915(c) Waiver Allocation and Transition Guide
All 2021 HAN Alerts
Registration Guide Dec 2016, Cipro Resistant Meningitidis - 08-06-2020, Remdesivir Update Guidance - 08-28 2020, COVID-19 Pre-Season - 09-11-2020, COVID-19 - 09-2020, COVID-19 - 01-16-2020, COVID-19 - 03-31-2020, COVID-19 -04-01-2020, COVID-19 - Directive Reporting Testing Data on Portal - 04-03-2020, COVID-19 - TB Testing Deferment - 04-44-2020, COVID-19 - 04-20-2020 , COVID-19 - 05-06-2020, COVID-19 - Menthol - 06-17-2020, COVID-19 - Antibody Testing - 07-02-2020, COVID-19 - NIH Summary - 07-28-2020, COVID-19 - Rapid Antigen Tests - 10-16-2020, COVID-19 - Crisis Staffing Tiers - 11-19-2020, COVID-19 - 12-03-2020, COVID-19 - Pfizer Vaccine Training Series For Clinicians, COVID-19 - 12-21-2020, COVID-19 - Phase 1 A - 12-21-2020 , COVID-19 - Releases Clinical Guidance Following VaST Technical Report - 06-25-2021, COVID-19 - 432 MIS-C Associated With COVID - 05-14-2020.DDSD COVID-19 Resumption of In Person Monitoring Visits and DDSD Core Class Room Training effective April 1 2022
Medical Cannabis Program - Program Update 03/22/2022